Cutler Group’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-500
Closed -$15K 6527
2021
Q2
$15K Hold
500
﹤0.01% 3586
2021
Q1
$12K Buy
+500
New +$12.5K ﹤0.01% 3687

Other funds holding RNLX

Cutler Group's RNLX Position: Q3 2021 in Review

Cutler Group sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2021, closing a stake of 500 shares — an estimated $15K sold.

Cutler Group first reported a position in RNLX in Q1 2021 and held it in 2 quarters. The position peaked at $15K in Q2 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q3 2021.

  • Cutler Group reported no remaining Renalytix plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Cutler Group sold 500 Renalytix plc American Depositary Shares shares in Q3 2021, an estimated $15K.
  • Cutler Group first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Cutler Group's Renalytix plc American Depositary Shares position peaked at $15K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2021.

Based on Cutler Group's 13F filing for Q3 2021, filed 26 Oct 2021.